bromfenac has been researched along with Pseudophakia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hess, J; Kauffman, L; Walter, K | 1 |
| Arimura, S; Inatani, M; Iwasaki, K; Matsumura, T; Takamura, Y; Takeda, R | 1 |
| Campa, C; Perri, P; Salsini, G | 1 |
| Bahrani, H; Fox, JE; Warren, KA | 1 |
| Chandler, SP; Gayton, JL; Gow, JA; Henderson, BA; Klier, SM; McNamara, TR | 1 |
4 trial(s) available for bromfenac and Pseudophakia
| Article | Year |
|---|---|
Topical bromfenac reduces multiple inflammatory cytokines in the aqueous humour of pseudophakic patients.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aqueous Humor; Benzophenones; Bromobenzenes; Cytokines; Female; Humans; Male; Prospective Studies; Pseudophakia | 2021 |
Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Cataract Extraction; Dexamethasone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Macula Lutea; Macular Edema; Male; Ophthalmic Solutions; Phenylacetates; Prospective Studies; Pseudophakia; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2018 |
NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzeneacetamides; Benzophenones; Bevacizumab; Bromobenzenes; Diclofenac; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Ketorolac; Macular Edema; Male; Middle Aged; Phenylacetates; Pseudophakia; Retina; Single-Blind Method; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
Safety and efficacy of bromfenac ophthalmic solution (Bromday) dosed once daily for postoperative ocular inflammation and pain.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract Extraction; Double-Blind Method; Endpoint Determination; Eye Pain; Female; Humans; Inflammation; Lens Implantation, Intraocular; Male; Ophthalmic Solutions; Pain, Postoperative; Postoperative Complications; Pseudophakia; Treatment Outcome; Uveitis, Anterior; Visual Acuity | 2011 |
1 other study(ies) available for bromfenac and Pseudophakia
| Article | Year |
|---|---|
Rate of pseudophakic cystoid macular edema using intraoperative and topical nonsteroidal antiinflammatory drugs alone without steroids.
Topics: Administration, Ophthalmic; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Female; Humans; Intraoperative Care; Ketorolac; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylephrine; Postoperative Care; Postoperative Complications; Pseudophakia; Retrospective Studies; Visual Acuity | 2020 |